title: Should combat troops be given the option of refusing investigational drug treatment?
authors.affiliation: Steptoe and Johnson, Washington, D.C., USA.
authors.forename: R P
authors.initials: RP
authors.lastname: Ryan
mesh_terms: D015507:Drugs, Investigational; D004992:Ethics, Medical; D006805:Human Experimentation; D006806:Human Rights / Q000331:legislation & jurisprudence; D006801:Humans; D007258:Informed Consent; D008889:Military Personnel; D018923:Persian Gulf Syndrome; D011729:Pyridostigmine Bromide; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015507:Drugs, Investigational; D011729:Pyridostigmine Bromide